Phase-1 trial of Ebola vaccine gets underway in Uganda
Global - Africa
Archived
•
October 15, 2026
•
Scientists in the southern Ugandan city of Masaka are conducting a phase I trial of a candidate vaccine against the deadly Ebola Bundibugyo virus disease (BDBV), a strain for which no licensed vaccine or effective treatment currently exists.
Source: Africanews | https://www.africanews.com/feed/rss - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



